Immunogenicity and safety of two novel human papillomavirus 4- and 9-valent vaccines in Chinese women aged 20–45 years: A randomized, blinded, controlled with Gardasil (type 6/11/16/18), phase III non-inferiority clinical trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of two novel human papillomavirus 4- and 9-valent vaccines in Chinese women aged 20–45 years: A randomized, blinded, controlled with Gardasil (type 6/11/16/18), phase III non-inferiority clinical trial

Published:2022-11 Issue:48 Volume:40 Page:6947-6955
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Shu Yajun,Yu Yebin,Ji Ying,Zhang Li,Li Yuan,Qin Haiyang,Huang Zhuhang,Ou Zhiqiang,Huang Meilian,Shen Qiong,Li Zehong,Hu Meng,Li Chunyun,Zhang Gaoxia,Zhang Jikai

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference45 articles.

1. Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14 years in Mexico;Arredondo;Vaccine,2021

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis;De Martel;Lancet Glob Health,2020

4. World Health Organization. Human Papillomavirus (HPV) and Cervical Cancer. (Updated on February 22, 2022). https://www.who.int/news-room/fact-sheets/detail/cervical-cancer. Accessed on July 26, 2022.

5. Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014;Li;Chin J Cancer Res,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosimilar second-generation human papillomavirus vaccines;The Lancet Infectious Diseases;2023-11

2. Recent Developments in Human Papillomavirus (HPV) Vaccinology;Viruses;2023-06-26

3. Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: A meta-analysis;Frontiers in Public Health;2023-02-17

4. Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females;Human Vaccines & Immunotherapeutics;2023-01-02

5. Side effects of vaccines;Side Effects of Drugs Annual;2023